Product Code: MD 9121
The global blood pressure cuffs market was valued at an estimated USD 909 million in 2024 and is projected to reach USD 1,399 million by 2029, at a CAGR of 9.0% during the forecast period. Growth in the market is primarily driven by the increasing prevalence of cardiovascular diseases, advancements in blood pressure monitoring, and increasing awareness of early diagnosis. As the population grows, the prevalence of hypertension and other cardiovascular diseases increases, and the demand for blood pressure monitoring devices increases The population over 65 years of age is growing at a faster rate than the younger population 65 years, according to World Population Prospects 2022 it is anticipated that the proportion of people over 65 in the world will increase from 10% in 2022 to 16% in 2050.
Scope of the Report |
Years Considered for the Study | 2022-2029 |
Base Year | 2023 |
Forecast Period | 2024-2029 |
Units Considered | Value (USD Million) |
Segments | By type, size, usage, age group, distribution channel, end user, and region |
Regions covered | North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries |
"The automated segment accounted for the highest CAGR of the blood pressure cuffs market in 2023, by type."
Based on type, the blood pressure cuffs market is segmented into automated and manual. Automated devices are routinely used by healthcare professionals for office/clinic and 24-hour ambulatory BP monitoring. Health care providers frequently use automated devices for office/hospital and 24-hour ambulatory BP monitoring. Automated blood pressure cuffs stand out in the BP cuff market over manual blood pressure cuffs due to their easy-to-use design that requires minimal training, easy communication and monitoring of health care systems health, and providing comfortable measurements. The growth of the automated segment is driven by the rising prevalence of hypertension and the increased adoption of home blood pressure monitoring.
"The 19 cm and above segment is projected to witness the highest growth rate in the blood pressure cuffs market, by size, during the forecast period."
The blood pressure cuffs market is segmented into 8-19 cm and 19 cm & above. Accurate BP measurement is essential for the proper diagnosis and management of hypertension, expensive R&D costs incurred by players in clinical settings and through self-measured blood pressure (SMBP) monitoring, is anticipated that the development of new technologies such as wireless cuffs will also help the segments growth in the coming years.
"The reusable segment accounted for the largest market share of blood pressure cuffs market, in 2023, by usage."
Based on usage, the blood pressure cuffs market is segmented into reusable and disposable. The large share of this segment is attributed to the large healthcare institutions, such as hospitals and nursing homes, find reusable cuffs more economical over time due to the reduced need for frequent replacements, initiatives to reduce medical waste, and policies and guidelines promoting the use of sustainable medical products support the adoption of reusable blood pressure cuffs.
"The adults segment accounted for the largest market share of blood pressure cuffs market, in 2023, by age group."
Based on age group, the blood pressure cuffs market is segmented into adults and infants & children. The large share of this segment is attributed to factors like unhealthy diets, sedentary lifestyles, stress, and increasing obesity rates in adults and children that contribute to the high prevalence of hypertension, necessitating regular monitoring and management of blood pressure.
"The offline segment accounted for the largest market share of blood pressure cuffs market, in 2023, by distribution channel."
Based on the distribution channel, the blood pressure cuffs market is segmented into offline and online. The large share of this segment is attributed to the increasing adoption of advanced blood pressure monitoring devices, the availability of blood pressure cuffs in pharmacies and retail stores, and supportive government initiatives, such as public health campaigns, subsidies, and favorable reimbursement policies for hypertension management.
"The homecare segment is projected to witness the highest growth rate in the blood pressure cuffs market, by end-user, during the forecast period."
Based on end user, the blood pressure cuffs market is segmented into hospitals, clinics, homes and other end users. The high growth rate of this segment is attributed to the convenience of monitoring blood pressure at home rather than making frequent visits to healthcare facilities, and innovations in blood pressure monitoring technology, such as automated cuffs, have made these devices more user-friendly and accurate, this has led to an increased preference for home-use blood pressure monitoring devices.
"The Asia Pacific region is projected to witness the highest growth rate in the blood pressure cuffs market during the forecast period."
The global blood pressure cuffs market is segmented into six regions - North America, Europe, Latin America, Asia Pacific, the Middle East & Africa, and the GCC Countries. The Asia Pacific market, which comprises Japan, India, China, and the Rest of Asia Pacific, is expected to offer significant growth opportunities to market players and is projected to register the highest CAGR in the blood pressure cuffs market during the forecast period. Government efforts to increase awareness about early disease diagnosis and regular health checkups, rising healthcare expenditure, and the increasing number of hospitals and clinical diagnostic laboratories, and growing awareness regarding the hypertension prevalence are some of the major factors driving the growth of the blood pressure cuffs market in the Asia Pacific.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 35%, Europe - 26%, Asia Pacific - 24%, Latin America - 12%, Middle East & Africa - 1%, and the GCC Countries - 2%
Lists of Companies Profiled in the Report:
Omron Corporation, Inc. (Japan), Baxter International Inc. (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), McKesson Corporation. (US), B Braun Melsungen AG (Germany), Halma plc (UK), OSI Systems, Inc. (US), American Diagnostic Corporation (US), Medline Industries, LP. (US), Microlife Corporation (Switzerland), BIOS Medical (UK), Accoson (UK), CellBios (India), Midmark Corporation (US), Withings (France), Spengler Holtex Group (France), Beurer (Germany), Technicuff (US), W.A. Baum Co., Inc. (US), BPL Medical Technologies (India), Boen Healthcare Co. Ltd (China), and Masimo (US).
Research Coverage:
In this report, the blood pressure cuffs market has been categorized based on type (automated, and manual), size (8-19 cm, and 19 cm & above), usage (reusable, and disposable) age group (adults, and infants & children) distribution channel (offline, and online) end user (hospitals, clinics, home care, and other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and the GCC Countries).
The report's coverage includes comprehensive details about the key factors impacting the growth of the blood pressure cuffs market, including opportunities, challenges, opportunities, and restraints. To offer insights into their business overview, services offered, significant strategies, acquisitions and partnerships, and recent developments related to the blood pressure cuffs market, a thorough analysis of the major industry players has been conducted. This study examines the competitive landscape of emerging blood pressure cuffs startups.
Reasons to buy this report:
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall blood pressure cuffs market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, trends, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers: (The increasing incidence of hypertension and cardiovascular diseases attributable to high blood pressure, and the increasing geriatric population prone to hypertension and related health conditions, and increased use of single-patient-use blood pressure cuffs to prevent hospital-acquired infections and Focus on Patient Safety and Accuracy), challenges (miscuffing or selecting an inappropriate cuff size, errors by physician- or health professional and technical limitations and accuracy issues), opportunities (The increasing adoption of advanced blood pressure monitoring devices (wireless blood pressure cuffs), and the rise of telehealth and remote patient monitoring services), and restraints (The availability of alternative methods and devices for monitoring blood pressure, lack of awareness about hypertension and the importance of regular blood pressure monitoring, and increasing transmission of HAI's due to reusable cuffs) influencing the growth of the in blood pressure cuffs market.
- Product Development/Innovation: Detailed insights on research & development activities and new product launches in the blood pressure cuffs market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the blood pressure cuffs market across varied regions.
- Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the blood pressure cuffs market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Omron Corporation, Inc. (Japan), Baxter International Inc. (US), and McKesson Corporation (US), among others, in the blood pressure cuffs market strategies.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 RECESSION IMPACT
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Key primary participants
- 2.1.2.2 Key data from primary sources
- 2.1.2.3 Key industry insights
- 2.1.2.4 Breakdown of interviews with experts
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.2 TOP-DOWN APPROACH
- 2.3 DATA TRIANGULATION
- 2.4 MARKET SHARE EVALUATION
- 2.5 RESEARCH ASSUMPTIONS
- 2.6 GROWTH FORECAST
- 2.7 RESEARCH LIMITATIONS
- 2.7.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7.2 SCOPE-RELATED LIMITATIONS
- 2.8 RISK ASSESSMENT
- 2.9 RECESSION IMPACT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BLOOD PRESSURE CUFFS MARKET
- 4.2 ASIA PACIFIC: BLOOD PRESSURE CUFFS MARKET, BY TYPE AND COUNTRY
- 4.3 BLOOD PRESSURE CUFFS MARKET, BY KEY COUNTRY
- 4.4 BLOOD PRESSURE CUFFS MARKET, REGIONAL MIX (2024-2029)
- 4.5 BLOOD PRESSURE CUFFS MARKET, DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Increasing incidence of hypertension and cardiovascular diseases attributable to high blood pressure
- 5.2.1.2 Rise in elderly population prone to hypertension and related health conditions
- 5.2.1.3 Surge in use of single-patient-use blood pressure cuffs to prevent hospital-acquired infections
- 5.2.2 RESTRAINTS
- 5.2.2.1 Availability of alternative methods and devices for monitoring blood pressure
- 5.2.2.2 Lack of hypertension awareness and need for regular blood pressure monitoring
- 5.2.2.3 Increasing transmission of healthcare-associated infections due to reusable cuffs
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Rising adoption of advanced blood pressure monitoring devices
- 5.2.3.2 Rising demand for telehealth and remote patient monitoring services
- 5.2.4 CHALLENGES
- 5.2.4.1 Miscuffing or selecting an inappropriate cuff size
- 5.2.4.2 Technical limitations and accuracy issues
- 5.2.4.3 Errors by physician or health professional
- 5.3 PRICING ANALYSIS
- 5.3.1 PRICING ANALYSIS, BY REGION
- 5.3.2 PRICING ANALYSIS, BY PRODUCT
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 SUPPLY CHAIN ANALYSIS
- 5.6 ECOSYSTEM ANALYSIS
- 5.7 PORTER'S FIVE FORCES ANALYSIS
- 5.7.1 THREAT OF NEW ENTRANTS
- 5.7.2 THREAT OF SUBSTITUTES
- 5.7.3 BARGAINING POWER OF SUPPLIERS
- 5.7.4 BARGAINING POWER OF BUYERS
- 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.8 REGULATORY LANDSCAPE
- 5.8.1 NORTH AMERICA
- 5.8.1.1 US
- 5.8.1.2 Canada
- 5.8.2 EUROPE
- 5.8.3 ASIA PACIFIC
- 5.8.3.1 Japan
- 5.8.3.2 Australia
- 5.8.3.3 Latin America
- 5.8.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGY
- 5.9.2 COMPLEMENTARY TECHNOLOGY
- 5.9.3 ADJACENT TECHNOLOGY
- 5.10 TRADE ANALYSIS
- 5.10.1 IMPORT SCENARIO
- 5.10.2 EXPORT SCENARIO
- 5.11 PATENT ANALYSIS
- 5.11.1 LIST OF MAJOR PATENTS
- 5.12 KEY CONFERENCES & EVENTS IN 2024-2025
- 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.14.2 BUYING CRITERIA
- 5.15 INVESTMENTS AND FUNDING SCENARIO
6 BLOOD PRESSURE CUFFS MARKET, BY TYPE
- 6.1 INTRODUCTION
- 6.2 AUTOMATED
- 6.2.1 GROWING USE IN AMBULATORY MONITORING AND HOME BLOOD PRESSURE MEASUREMENT TO DRIVE MARKET
- 6.3 MANUAL
- 6.3.1 USE AS STANDARD DEVICE FOR ACCURATE BLOOD PRESSURE MEASUREMENT TO FUEL MARKET GROWTH
7 BLOOD PRESSURE CUFFS MARKET, BY SIZE
- 7.1 INTRODUCTION
- 7.2 8-19 CM
- 7.2.1 RISE IN OBESITY AMONG CHILDREN AND ADOLESCENTS TO DRIVE DEMAND
- 7.3 19 CM AND ABOVE
- 7.3.1 INCREASING PREVALENCE OF HYPERTENSION AMONG ADULTS TO FUEL DEMAND
8 BLOOD PRESSURE CUFFS MARKET, BY USAGE
- 8.1 INTRODUCTION
- 8.2 REUSABLE
- 8.2.1 LOW COST AND HIGH DURABILITY ASSOCIATED WITH REUSABLE BLOOD PRESSURE CUFFS TO DRIVE DEMAND
- 8.3 DISPOSABLE
- 8.3.1 PRESSING NEED FOR REDUCING TRANSMISSION OF HEALTHCARE-ASSOCIATED INFECTIONS TO DRIVE DEMAND
9 BLOOD PRESSURE CUFFS MARKET, BY AGE GROUP
- 9.1 INTRODUCTION
- 9.2 ADULTS
- 9.2.1 RISING PREVALENCE OF HYPERTENSION AMONG ADULTS AND NEED FOR CHRONIC DISEASE MANAGEMENT TO DRIVE DEMAND
- 9.3 INFANTS & CHILDREN
- 9.3.1 GROWING NEED FOR EARLY DETECTION AND MANAGEMENT OF PEDIATRIC HYPERTENSION TO FUEL DEMAND
10 BLOOD PRESSURE CUFFS MARKET, BY DISTRIBUTION CHANNEL
- 10.1 INTRODUCTION
- 10.2 OFFLINE
- 10.2.1 DEVELOPMENT AND EXPANSION OF HEALTHCARE CENTERS AND DISTRIBUTION NETWORKS TO DRIVE MARKET
- 10.3 ONLINE
- 10.3.1 INCREASED ACCESS TO WIDE RANGE OF PRODUCTS FOR PATIENTS FROM RURAL OR REMOTE AREAS TO DRIVE MARKET
11 BLOOD PRESSURE CUFFS MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 HOSPITALS
- 11.2.1 ABILITY TO HANDLE HIGH INSTALLATION COSTS RELATED TO BLOOD PRESSURE MONITORING DEVICES TO DRIVE MARKET
- 11.3 CLINICS
- 11.3.1 EASY ACCESSIBILITY OF CLINICS AND AVAILABILITY OF TRAINED PROFESSIONALS TO DRIVE MARKET
- 11.4 HOMECARE
- 11.4.1 ACCESSIBILITY OF PERSONAL BLOOD PRESSURE MONITORS FOR MANAGING HEALTH OUTSIDE CLINICAL SETTINGS TO DRIVE DEMAND
- 11.5 OTHER END USERS
12 BLOOD PRESSURE CUFFS MARKET, BY REGION
- 12.1 INTRODUCTION
- 12.2 NORTH AMERICA
- 12.2.1 RECESSION IMPACT
- 12.2.2 US
- 12.2.2.1 Prevalence of hypertension and need for blood pressure monitoring devices to drive market
- 12.2.3 CANADA
- 12.2.3.1 Aging demography and government initiatives for cardiovascular disease prevention to boost demand for cuffs
- 12.3 EUROPE
- 12.3.1 RECESSION IMPACT
- 12.3.2 GERMANY
- 12.3.2.1 Well-developed healthcare system and stringent regulations for medical device industry to drive market
- 12.3.3 UK
- 12.3.3.1 Growing incidence of hypertension and well-established healthcare infrastructure to drive market
- 12.3.4 FRANCE
- 12.3.4.1 Surveillance and measures to mitigate risk of infectious diseases to boost demand
- 12.3.5 ITALY
- 12.3.5.1 Increasing healthcare expenditure to drive market
- 12.3.6 SPAIN
- 12.3.6.1 Government efforts to improve healthcare infrastructure to fuel demand
- 12.3.7 REST OF EUROPE
- 12.4 ASIA PACIFIC
- 12.4.1 RECESSION IMPACT
- 12.4.2 JAPAN
- 12.4.2.1 Growing elderly population and well-developed healthcare system to drive market
- 12.4.3 CHINA
- 12.4.3.1 Rising number of hospitals and increasing prevalence of cardiovascular diseases to boost market
- 12.4.4 INDIA
- 12.4.4.1 Advanced policy initiatives and substantial medical device investments to boost domestic production of cuffs
- 12.4.5 REST OF ASIA PACIFIC
- 12.5 LATIN AMERICA
- 12.5.1 RECESSION IMPACT
- 12.5.2 BRAZIL
- 12.5.2.1 Surge in chronic conditions to boost demand for blood pressure monitoring devices
- 12.5.3 MEXICO
- 12.5.3.1 Increasing demand for advanced medical equipment to drive market
- 12.5.4 REST OF LATIN AMERICA
- 12.6 MIDDLE EAST & AFRICA
- 12.6.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET
- 12.6.2 RECESSION IMPACT
- 12.7 GCC COUNTRIES
13 COMPETITIVE LANDSCAPE
- 13.1 OVERVIEW
- 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 13.3 REVENUE ANALYSIS, 2021-2023
- 13.4 MARKET SHARE ANALYSIS, 2023
- 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 13.5.1 STARS
- 13.5.2 EMERGING LEADERS
- 13.5.3 PERVASIVE PLAYERS
- 13.5.4 PARTICIPANTS
- 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 13.5.5.1 Company footprint
- 13.5.5.2 Usage footprint
- 13.5.5.3 Age group footprint
- 13.5.5.4 End user footprint
- 13.5.5.5 Region footprint
- 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 13.6.1 PROGRESSIVE COMPANIES
- 13.6.2 RESPONSIVE COMPANIES
- 13.6.3 DYNAMIC COMPANIES
- 13.6.4 STARTING BLOCKS
- 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 13.6.5.1 List of key startups/SMEs
- 13.7 COMPANY VALUATION AND FINANCIAL METRICS
- 13.8 BRAND/PRODUCT COMPARISON ANALYSIS
- 13.9 COMPETITIVE SCENARIO AND TRENDS
- 13.9.1 DEALS
- 13.9.2 EXPANSIONS
14 COMPANY PROFILES
- 14.1 KEY PLAYERS
- 14.1.1 OMRON CORPORATION
- 14.1.1.1 Business overview
- 14.1.1.2 Products offered
- 14.1.1.3 MnM view
- 14.1.1.3.1 Key strengths
- 14.1.1.3.2 Strategic choices
- 14.1.1.3.3 Weaknesses/Competitive threats
- 14.1.2 BAXTER INTERNATIONAL INC.
- 14.1.2.1 Business overview
- 14.1.2.2 Products offered
- 14.1.2.3 Recent developments
- 14.1.2.4 MnM view
- 14.1.2.4.1 Key strengths
- 14.1.2.4.2 Strategic choices
- 14.1.2.4.3 Weaknesses/Competitive threats
- 14.1.3 KONINKLIJKE PHILIPS N.V.
- 14.1.3.1 Business overview
- 14.1.3.2 Products offered
- 14.1.3.3 MnM view
- 14.1.3.3.1 Key strengths
- 14.1.3.3.2 Strategic choices
- 14.1.3.3.3 Weaknesses/Competitive threats
- 14.1.4 GE HEALTHCARE
- 14.1.4.1 Business overview
- 14.1.4.2 Products offered
- 14.1.4.3 Recent developments
- 14.1.5 MCKESSON CORPORATION
- 14.1.5.1 Business overview
- 14.1.5.2 Products offered
- 14.1.6 B. BRAUN MELSUNGEN AG
- 14.1.6.1 Business overview
- 14.1.6.2 Products offered
- 14.1.7 HALMA PLC
- 14.1.7.1 Business overview
- 14.1.7.2 Products offered
- 14.1.7.3 Recent developments
- 14.1.8 OSI SYSTEMS, INC.
- 14.1.8.1 Business overview
- 14.1.8.2 Products offered
- 14.1.8.3 Recent developments
- 14.1.9 AMERICAN DIAGNOSTIC CORPORATION
- 14.1.9.1 Business overview
- 14.1.9.2 Products offered
- 14.1.10 MEDLINE INDUSTRIES, LP.
- 14.1.10.1 Business overview
- 14.1.10.2 Products offered
- 14.1.10.3 Recent developments
- 14.1.11 MICROLIFE CORPORATION
- 14.1.11.1 Business overview
- 14.1.11.2 Products offered
- 14.1.12 BIOS MEDICAL
- 14.1.12.1 Business overview
- 14.1.12.2 Products offered
- 14.1.13 ACCOSON
- 14.1.13.1 Business overview
- 14.1.13.2 Products offered
- 14.1.13.3 Recent developments
- 14.2 OTHER PLAYERS
- 14.2.1 CELLBIOS
- 14.2.2 MIDMARK CORPORATION
- 14.2.3 WITHINGS
- 14.2.4 SPENGLER HOLTEX GROUP
- 14.2.5 BEURER
- 14.2.6 TECHNICUFF
- 14.2.7 W.A. BAUM CO., INC.
- 14.2.8 BPL MEDICAL TECHNOLOGIES
- 14.2.9 BOEN HEALTHCARE CO., LTD
- 14.2.10 MASIMO
15 APPENDIX
- 15.1 DISCUSSION GUIDE
- 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 15.3 CUSTOMIZATION OPTIONS
- 15.4 RELATED REPORTS
- 15.5 AUTHOR DETAILS